The clinical effects of recombinant human brain natriuretic peptide combined with sacubitril valsartan in treating acute myocardial infarction patients with acute heart failure and the effects of serum galectin-3 and pentraxin-3 levels

XU Wenke, SHI Yongen, MENG Xiangbin, ZHANG Weijie, GAO Chuanyu

PDF(2000 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(2000 KB)
World Clinical Drug ›› 2021, Vol. 42 ›› Issue (05) : 381-387. DOI: 10.13683/j.wph.2021.05.012
Topic

The clinical effects of recombinant human brain natriuretic peptide combined with sacubitril valsartan in treating acute myocardial infarction patients with acute heart failure and the effects of serum galectin-3 and pentraxin-3 levels

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 42(05): 381-387 https://doi.org/10.13683/j.wph.2021.05.012

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2000 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉